SAN DIEGO — Patients with COPD on budesonide/glycopyrrolate/formoterol fumarate had a lower risk for cardiopulmonary outcomes, according to research presented at the American Thoracic Society International Conference.“Patients with COPD are at risk of cardiovascular and pulmonary events,” David Singh, MD, ETHOS study investigator, told Healio. “Just one COPD exacerbation